camptothecin has been researched along with rocaglamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carcache de Blanco, EJ; Chai, H; Farnsworth, NR; Han, AR; Kardono, LB; Kim, JA; Kinghorn, AD; Lantvit, DD; Riswan, S; Swanson, SM | 1 |
| Adcock, AF; Ayers, S; Carcache de Blanco, EJ; Graf, TN; Kroll, DJ; Matthew, S; Oberlies, NH; Pearce, CJ; Shen, Q; Swanson, SM; Wani, MC | 1 |
2 other study(ies) available for camptothecin and rocaglamide
| Article | Year |
|---|---|
Cytotoxic xanthone constituents of the stem bark of Garcinia mangostana (mangosteen).
Topics: Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Garcinia mangostana; HT29 Cells; Humans; Indonesia; Models, Biological; Plants, Medicinal; Xanthones | 2009 |
Resorcylic acid lactones with cytotoxic and NF-κB inhibitory activities and their structure-activity relationships.
Topics: Anti-Bacterial Agents; Fungi; Humans; Hydroxybenzoates; Lactones; Molecular Structure; NF-kappa B; Resorcinols; Structure-Activity Relationship; Zearalenone | 2011 |